Oragenics Files 8-K Report
Ticker: OGEN · Form: 8-K · Filed: Aug 12, 2024 · CIK: 1174940
Sentiment: neutral
Topics: reporting, corporate-filing
Related Tickers: OGEN
TL;DR
Oragenics filed an 8-K, standard reporting stuff, no major news yet.
AI Summary
On August 12, 2024, Oragenics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or material events were detailed in the provided excerpt, but it indicates a standard reporting update.
Why It Matters
This filing serves as a public record of Oragenics, Inc.'s corporate activities and financial reporting, providing transparency to investors and stakeholders.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report without immediate disclosure of significant risks or material changes.
Key Players & Entities
- Oragenics, Inc. (company) — Registrant
- August 12, 2024 (date) — Date of earliest event reported
FAQ
What is the primary purpose of this 8-K filing for Oragenics, Inc.?
The primary purpose of this 8-K filing is to report on "Other Events" and "Financial Statements and Exhibits" as of August 12, 2024.
What is Oragenics, Inc.'s state of incorporation?
Oragenics, Inc. is incorporated in Florida (FL).
What is the IRS Employer Identification Number for Oragenics, Inc.?
The IRS Employer Identification Number for Oragenics, Inc. is 59-3410522.
What is the principal executive office address for Oragenics, Inc.?
The principal executive office address for Oragenics, Inc. is 1990 Main Street, Suite 750, Sarasota, FL 34236.
What is the telephone number for Oragenics, Inc.?
The telephone number for Oragenics, Inc. is 813-286-7900.
Filing Stats: 456 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2024-08-12 08:30:14
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 16KB
- 0001493152-24-031163.txt ( ) — 230KB
- ogen-20240812.xsd (EX-101.SCH) — 3KB
- ogen-20240812_lab.xml (EX-101.LAB) — 33KB
- ogen-20240812_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 12 th day of August, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer